FrancophonIA/ELRC3.0 huggingface dataset:
English: This is a procedure where one Member State (the ‘reference Member State', in this instance France) assesses a medicine with a view to granting a marketing authorisation that will be valid in that country as well as in other Member States (the ‘concerned Member States', in this instance Austria, Belgium, Germany, Italy, Poland, Romania, Slovakia and
Croatian: To je postupak u kojem jedna država članica („referenta država članica”, u ovom slučaju Francuska) ocjenjuje lijek s ciljem izdavanja odobrenja za stavljanje lijeka u promet koje će biti na snazi u toj državi kao i ostalim državama članicama („državama članicama u postupku”, u ovom slučaju Austrija, Belgija, Njemačka, Italija, Poljska,
English: Because the treatment cycle of 91 days is longer than that of most other combined contraceptives (which is normally 28 days), Seasonique is known as an extended cycle oral contraceptive.
Croatian: Budući da je terapijski ciklus od 91 dana dulji od ciklusa većine drugih kombiniranih kontraceptiva (koji normalno iznosi 28 dana), Seasonique je poznat kao oralni kontraceptiv produljenog ciklusa.
English: For 84 days the woman takes the tablets containing levonorgestrel and ethinylestradiol and then for the remaining 7 days she takes tablets containing only ethinylestradiol.
Croatian: Tijekom 84 dana žena uzima tablete koje sadrže levonorgestrel i etinilestradiol, a zatim preostalih 7 dana uzima tablete koje sadrže samo etinilestradiol.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that the benefits of Seasonique outweigh its risks and that marketing authorisation should be granted in France and in the following EU Member States: Austria, Belgium, Germany, Italy, Poland, Romania, Slovakia and Slovenia.
Croatian: Odbor za lijekove za humanu uporabu (CHMP) pri Agenciji zaključio je da koristi lijeka Seasonique nadmašuju njegove rizike i da se odobrenje za stavljanje u promet treba izdati u Francuskoj, te u sljedećim državama članicama EU: Austriji, Belgiji, Njemačkoj, Italiji, Poljskoj, Rumunjskoj, Slovačkoj i Sloveniji.
English: However, the Member States were not able to reach an agreement and the French medicines agency referred the matter to the CHMP for arbitration on 3 February 2014.
Croatian: No, države članice nisu uspjele postići dogovor te je francuska agencija za lijekove uputila predmet CHMP-u na arbitražu 3. ožujka 2014.
English: Teva Pharma submitted an application to the French medicines agency (ANSM) for Seasonique to be authorised in a decentralised procedure.
Croatian: Tvrtka Teva Pharma dostavila je zahtjev francuskoj agenciji za lijekove (ANSM-u) za izdavanje odobrenja za Seasonique u decentraliziranom postupku.
English: Levonorgestrel (a progestogen) and ethinylestradiol (an oestrogen) are both hormones and Seasonique is what is known as a ‘combined hormonal contraceptive'.
Croatian: Levonorgestrel (progestogen) i etinilestradiol (estrogen) su hormoni, a Seasonique je lijek koji je poznat pod nazivom „kombinirani hormonalni kontraceptiv”.
English: Combined hormonal contraceptives work by stopping the release of eggs from the ovaries and by causing changes in the cervix and the lining of the womb that make it harder for a sperm to reach an egg and for a fertilised egg to implant in the womb.
Croatian: Kombinirani hormonalni kontraceptivi djeluju zaustavljajući otpuštanje jajašca iz jajnika i uzrokujući promjene u vratu maternice i ovojnici maternice što otežava spermi da dosegne jajašce te da se oplođeno jajašce ugnijezdi u maternici.
English: After evaluating data from studies and post-marketing data from outside the EU, the CHMP was of the view that there was adequate evidence that Seasonique is an effective contraceptive.
Croatian: Nakon procjene podataka dostupnih iz ispitivanja kao i podataka nakon stavljanja lijeka u promet prikupljenih na području izvan EU-a, CHMP je smatrao da postoje primjereni dokazi da je Seasonique djelotvoran kontraceptiv.
English: Women taking Seasonique will have longer intervals between withdrawal bleeding but may experience more irregular bleeding.
Croatian: Žene koje uzimaju Seasonique imat će duže intervale između krvarenja nakon prestanka uzimanja lijeka, no mogu imati neredovitije menstruacije.
English: On 26 June 2014, the European Medicines Agency completed an arbitration procedure following a disagreement among Member States of the European Union (EU) regarding the authorisation of the oral contraceptive Seasonique.
Croatian: Europska agencija za lijekove završila je arbitražni postupak nakon neslaganja među državama članicama Europske unije (EU) u vezi s odobrenjem za stavljanje u promet oralnog kontracepcijskog sredstva Seasonique.
English: The grounds for the referral related to concerns raised by the German medicines agency about the effectiveness of Seasonique in preventing pregnancy and the irregular bleeding experienced by women taking the contraceptive.
Croatian: Razlozi za postupak upućivanja odnosili su se na zabrinutost koju je izrazila njemačka agencija za lijekove u vezi s djelotvornošću lijeka Seasonique u sprječavanju trudnoće i neredovitih menstruacija u žena koje uzimaju taj kontraceptiv.
English: The Committee therefore concluded that the benefits of Seasonique outweigh its risks and recommended that marketing authorisation be granted in the reference and concerned Member States.
Croatian: Stoga je Odbor zaključio da koristi lijeka Seasonique nadmašuju njegove rizike i preporučio je da se odobrenje za stavljanje lijeka u promet izda kako u referentnoj državi članici, tako i u državama članicama u postupku.
English: The Committee also noted that the irregular bleeding reported with Seasonique has not made women less likely to keep to their treatment and adequate information about the risk of irregular bleeding is included in the package leaflet.
Croatian: Odbor je također napomenuo kako neredovita menstruacija prijavljena pri primjeni lijeka Seasonique nije smanjila vjerojatnost da će žene zadržati svoju terapiju, a primjerene informacije o riziku od neredovite menstruacije uključene su u uputu o lijeku.
English: This summary was last updated in 12-2016.
Croatian: Ovaj sažetak je posljednji put ažuriran u 12. 2016.
English: Treatment should be started and monitored by a doctor who has experience in the management of chronic hepatitis C.
Croatian: Liječenje mora započeti i nadzirati liječnik s iskustvom u liječenju kroničnog hepatitisa C.
English: The dose and duration of treatment is based on the patient's body weight and on the medicine used in combination with it.
Croatian: Doza i trajanje liječenja ovise o tjelesnoj težini bolesnika i lijeku koji se primjenjuje u kombinaciji.
English: The full EPAR for Ribavirin Teva can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR za lijek Ribavirin Teva Pharma B.V. nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Ribavirin Teva Pharma B.V. is taken with food each day in two divided doses (morning and evening).
Croatian: Ribavirin Teva Pharma B.V. uzima se s hranom svaki dan u dvjema odvojenim dozama (ujutro i navečer).
English: Ribavirin Teva Pharma B.V. can also be used in adults (aged 18 years and older) whose disease has come back after previous treatment.
Croatian: Ribavirin Teva Pharma B.V. može se primjenjivati i u odraslih bolesnika (u dobi od 18 godina i starijih) kojima se bolest vratila nakon prethodnog liječenja.
English: This means that Ribavirin Teva Pharma B.V. contains the same active substance and works in the same way as a ‘reference medicine' already authorised in the European Union (EU) called Rebetol.
Croatian: To znači da Rivabirin Teva Pharma B.V. sadržava istu djelatnu tvar i djeluje na isti način kao i „referentni lijek” koji je već odobren u Europskoj uniji (EU) pod nazivom Rebetol.
English: Studies on the benefits and risks of the active substance in the approved uses have already been carried out with the reference medicine, Rebetol and do not need to be repeated for Ribavirin Teva Pharma B.V.
Croatian: Ispitivanja o koristima i rizicima djelatne tvari u odobrenim primjenama već su provedena za referentni lijek Rebetol te ih ne treba ponavljati za lijek Rivabirin Teva Pharma B.V.
English: Ribavirin Teva Pharma B.V. must never be used on its own but only together with interferon alfa 2b (another medicine used in hepatitis).
Croatian: Ribavirin Teva Pharma B.V. ne smije se nikada uzimati sam nego zajedno s interferonom alfa-2b (još jedan lijek protiv hepatitisa).
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Ribavirin Teva Pharma B.V. has been shown to have comparable quality and to be bioequivalent to Rebetol.
Croatian: Odbor za lijekove za humanu uporabu (CHMP) pri Agenciji zaključio je kako je, u skladu sa zahtjevima EU-a, lijek Ribavirin Teva Pharma B.V. dokazao usporedivu kakvoću te da je bioekvivalentan lijeku Rebetol.
English: Ribavirin Teva Pharma B.V. available as tablets (200 and 400 mg).
Croatian: Ribavirin Teva Pharma B.V. dostupan je u obliku tableta (200 i 400 mg).
English: Ribavirin Teva Pharma B.V. on its own has no effect on eliminating the hepatitis C virus from the body.
Croatian: Ribavirin Teva Pharma B.V. sam po sebi nema učinka na uklanjanje virusa hepatitisa C iz organizma.
English: Because Ribavirin Teva Pharma B.V. is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Croatian: Budući da je Ribavirin Teva Pharma B.V. generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
English: Ribavirin Teva Pharma B.V.is thought to interfere with the production or action of viral DNA and RNA, which are needed for viruses to survive and multiply.
Croatian: Smatra se da Ribavirin Teva Pharma B.V. interferira s proizvodnjom ili djelovanjem DNK i RNK virusa, koji su nužni kako bi virusi preživjeli i umnožavali se.
English: Ribavirin Teva Pharma B.V. is used in patients who have not been treated before for all types of hepatitis C except for genotype 1, as long as the liver is still working normally and hepatitis C virus can be found in the blood.
Croatian: U bolesnika koji nikada nisu bili liječeni, Ribavirin Teva Pharma B.V. primjenjuje se protiv svih tipova hepatitisa C osim genotipa 1, sve dok im jetra još uvijek normalno radi a u krvi se može naći virus hepatitisa C.
English: The company also carried out studies that showed that it is ‘bioequivalent' to the reference medicine.
Croatian: Tvrtka je provela i ispitivanja koja su pokazala da je ovaj lijek bioekvivalentan referentnom lijeku.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Ribavirin Teva Pharma B.V. have been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Ribavirin Teva Pharma B.V. nalaze se u sažetku opisa svojstava lijeka i u uputi o lijeku.
English: The European Commission granted a marketing authorisation valid throughout the EU for Ribavirin Teva Pharma B.V. on 1 July 2009.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje je za lijek Ribavirin Teva Pharma B.V. na snazi u Europskoj uniji od 1. srpnja 2009.
English: The dose may need to be adjusted for patients who experience side effects.
Croatian: U bolesnika kojima nastanu nuspojave može biti potrebno prilagoditi dozu.
English: Ribavirin Teva Pharma B.V. is a medicine used to treat long-term hepatitis C (a disease of the liver due to infection with the hepatitis C virus) in patients aged three years and older.
Croatian: Ribavirin Teva Pharma B.V. lijek je koji se primjenjuje za liječenje kroničnog hepatitisa C (bolest jetre zbog infekcije virusom hepatitisa C) u bolesnika u dobi od tri i više godina.
English: What measures are being taken to ensure the safe and effective use of Ribavirin Teva Pharma B.V.?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Ribavirin Teva Pharma B.V.?
English: For more information about treatment with Ribavirin Teva Pharma B.V., read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o liječenju lijekom Ribavirin Teva Pharma B.V. pročitajte u uputi o lijeku (također dio EPAR-a), odnosno obratite se svom liječniku ili ljekarniku.
English: This is a summary of the European public assessment report (EPAR) for Ribavirin Teva Pharma B.V.
Croatian: Ovo je sažetak europskoga javnog izvješća o procjeni (EPAR) lijeka Rivabirin Teva Pharma B.V.
English: Therefore, the CHMP's view was that, as for Rebetol, the benefits outweigh the identified risks.
Croatian: Stoga je stav CHMP-a da korist nadmašuje identificirani rizik, kao i za lijek Rebetola.
English: For practical information about using Ribavirin Teva Pharma B.V., patients should read the package leaflet or contact their doctor or pharmacist.
Croatian: Praktične informacije o primjeni lijeka Rivabirin Teva Pharma B.V. bolesnici trebaju pročitati u uputi o lijeku, odnosno obratiti se svom liječniku ili ljekarniku.
English: Ribavirin Teva Pharma B.V. is a ‘generic medicine'.
Croatian: Rivabirin Teva Pharma B.V. je „generički lijek”.
English: The Committee recommended that Ribavirin Teva Pharma B.V. be approved for use in the EU.
Croatian: Odbor je preporučio davanje odobrenja za stavljanje lijeka Ribavirin Teva Pharma B.V. u promet u EU-u.
English: What are the benefits and risks of Ribavirin Teva Pharma B.V.?
Croatian: Koje su koristi i rizici lijeka Ribavirin Teva Pharma B.V.?
English: It is not intended to provide practical advice on how to use Ribavirin Teva Pharma B.V.
Croatian: Svrha sažetka nije davati praktične savjete o primjeni lijeka Rivabirin Teva Pharma B.V.
English: What is Ribavirin Teva Pharma B.V. and what is it used for?
Croatian: Što je Rivabirin Teva Pharma B.V. i za što se koristi?
English: As for every medicine, the company provided studies on the quality of Ribavirin Teva Pharma B.V.
Croatian: Kao i za svaki lijek, tvrtka je omogućila ispitivanja kakvoće lijeka Rivabirin Teva Pharma B.V.
English: The active substance in Ribavirin Teva Pharma B.V., ribavirin, is an antiviral belonging to the class ‘nucleoside analogues'.
Croatian: Ribavirin, djelatna tvar u lijeku Ribavirin Teva Pharma B.V., antivirusni je lijek koji pripada skupini lijekova pod nazivom „analozi nukleozida“.
English: Ribavirin Teva Pharma B.V. can only be obtained with a prescription.
Croatian: Lijek Ribavirin Teva Pharma B.V. izdaje se samo na recept.
English: Other information about Ribavirin Teva Pharma B.V.
Croatian: Ostale informacije o lijeku Ribavirin Teva Pharma B.V.
English: Why is Ribavirin Teva Pharma B.V. approved?
Croatian: Zašto je lijek Ribavirin Teva Pharma B.V. odobren?
English: How is Ribavirin Teva Pharma B.V. used?
Croatian: Kako je Ribavirin Teva Pharma B.V. ispitivan?
English: How does Ribavirin Teva Pharma B.V. work?
Croatian: Kako se Ribavirin Teva Pharma B.V. koristi?
English: Intravenous use vial (glass)
Croatian: Primjena u venu Bočica (staklena)
English: 2 mg/ml
Croatian: 2 mg/ml Koncentrat za otopinu za infuziju
English: It may also cause damage to your unborn baby.
Croatian: Također može naškoditi Vašem nerođenom djetetu.
English: County Cork Ireland
Croatian: County Cork Irska
English: Talk to your doctor about the best contraception for you.
Croatian: Razgovarajte sa svojim liječnikom o najboljoj kontracepciji za Vas.
English: Avda de la Industria, 30
Croatian: Avda de la Industria, 30 Alcobendas
English: You should not use this medicine during pregnancy.
Croatian: Ne smijete primjenjivati ovaj lijek tijekom trudnoće.
English: This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.
Croatian: Ovaj se lijek ne smije miješati s drugim lijekovima osim onih navedenih u dijelu 6.6.
English: Treatment cycles on both arms were repeated every 2 weeks.
Croatian: Ciklusi liječenja u obje su se skupine ponavljali svaka 2 tjedna.
English: The safety and efficacy of Cyramza in children and adolescents (<18 years) has not been established.
Croatian: Sigurnost i djelotvornost lijeka Cyramza u djece i adolescenata (< 18 godina) nisu ustanovljene.
English: Overall survival, months
Croatian: Ukupno preživljenje, mjeseci
English: This cancer treatment will be given to you by a doctor or nurse.
Croatian: Ovaj lijek za liječenje raka dat će Vam liječnik ili medicinska sestra.
English: Lilly France Fegersheim 2 rue du Colonel Lilly 67640 Fegersheim France
Croatian: Lilly France Fegersheim 2 rue du Colonel Lilly 67640 Fegersheim Francuska
English: Stomatitis/Mucositis 2
Croatian: Stomatitis/mukozitis 2
English: The number of infusions you will receive depends on how you are responding to treatment.
Croatian: Broj infuzija koje ćete primiti ovisi o Vašem odgovoru na liječenje.
English: If you are unsure, ask your doctor, pharmacist or nurse if there are any reasons why you can't use these medicines.
Croatian: Ako niste sigurni, upitajte svog liječnika, ljekarnika ili medicinsku sestru postoji li bilo koji razlog zašto ne biste smjeli primati te lijekove.
English: Aspartate aminotransferase (AST) /Alanine aminotransferase (ALT)
Croatian: aspartat aminotransferaza (AST)/alanin aminostransferaza (ALT)
English: Before starting treatment you must tell your doctor if you are pregnant or breast-feeding, think you may be pregnant or you are planning to have a baby.
Croatian: Prije početka liječenja morate reći liječniku ako ste trudni ili dojite, mislite da biste mogli biti trudni ili planirate imati dijete.
English: Please read the package leaflets for the other medicines that are part of your treatment, to see if they are suitable for you.
Croatian: Pročitajte upute o lijeku za ostale lijekove koji su dio Vaše terapije, kako biste provjerili jesu li oni pogodni za Vas.
English: The majority of events occurred during or following a first or second ramucirumab infusion.
Croatian: Većina događaja nastupila je tijekom ili nakon prve ili druge infuzije ramucirumaba.
English: Date of first authorisation: 19 December 2014 Date of latest renewal: 26 September 2019
Croatian: Datum posljednje obnove odobrenja: 26. rujna 2019.
English: Consider use of colonystimulating factor prior to next cycle.
Croatian: Razmotriti primjenu faktora stimulacije kolonija prije sljedećeg ciklusa.
English: Alcobendas 28108 Madrid Spain
Croatian: 28108 Madrid Španjolska
English: - have high blood pressure.
Croatian: - imate povišen krvni tlak.
English: This includes medicines obtained without a prescription and herbal medicines.
Croatian: To uključuje lijekove koje ste nabavili bez recepta i biljne lijekove.
English: The final total volume in the container should be 250 ml.
Croatian: Konačan ukupan volumen u spremniku mora biti 250 ml.
English: In such cases, your doctor will perform regular blood tests to monitor the risk of bleeding.
Croatian: U takvim će slučajevima liječnik redovito raditi krvne pretrage kako bi nadzirao rizik od krvarenja.
English: <1.5 x upper limit of normal value (ULN)
Croatian: < 1,5 x gornja granica normale (GGN)
English: - Elderly people with lung cancer: Your doctor will carefully evaluate the most appropriate treatment for you.
Croatian: - starije osobe s rakom pluća: Vaš će liječnik pažljivo odrediti koje je liječenje najprikladnije za
English: - if you are allergic to ramucirumab or any of the other ingredients of this medicine (listed in section 6).
Croatian: - ako ste alergični na ramucirumab ili neki drugi sastojak ovoga lijeka (naveden u dijelu 6).
English: There is no data on overdose in humans.
Croatian: Nema podataka o predoziranju u ljudi.
English: In most cases hypertension was managed using standard antihypertensive treatment.
Croatian: U većini se slučajeva hipertenziju uspjelo kontrolirati standardnim antihipertenzivnim liječenjem.
English: Very common (≥1/10) Common (≥1/100 to <1/10) Uncommon (≥1/1,000 to <1/100) Rare (≥1/10,000 to <1/1,000) Very rare (<1/10,000)
Croatian: često (≥1/100 i <1/10) manje često (≥1/1000 i <1/100) rijetko (≥1/10 000 i <1/1000) vrlo rijetko (<1/10 000)
English: Cyramza should not be given to patients under the age of 18 years because there is no information about how it works in this age group.
Croatian: Cyramza se ne smije primjenjivati u bolesnika mlađih od 18 godina jer nema podataka o tome kako lijek djeluje u toj dobnoj skupini.
English: Aspirin use at doses up to 325 mg/day was permitted (see section 5.1).
Croatian: Dopuštena je bila primjena aspirina u dozama do 325 mg/dan (vidjeti dio 5.1).
English: No dose reductions are recommended (see sections 4.4 and 5.1).
Croatian: Ne preporučuje se smanjenje doze (vidjeti dijelove 4.4 i 5.1).
English: Your doctor or hospital pharmacist will calculate your body surface area by measuring your height and weight and will work out the right dose for you.
Croatian: Vaš liječnik ili bolnički ljekarnik izračunat će Vašu tjelesnu površinu mjerenjem Vaše visine i težine te će na temelju toga odrediti točnu dozu za Vas.
English: In case of overdose, supportive therapy should be used.
Croatian: U slučaju predoziranja treba uvesti potpornu terapiju.
English: (see section 4.4).
Croatian: (vidjeti dio 4.2).
English: This is equivalent to approximately 4% of the recommended maximum daily dietary intake of sodium for an adult.
Croatian: To odgovara približno 4% preporučenog maksimalnog dnevnog unosa natrija za odraslu osobu.
English: A minimal grade of inflammation and/or mononuclear cell infiltration was seen in several organs.
Croatian: Primijećen je minimalan stupanj upale i/ili infiltracije mononuklearnih stanica u nekoliko organa.
English: The primary endpoint was overall survival.
Croatian: Primarna mjera ishoda bilo je ukupno preživljenje.
English: Animal studies are insufficient with respect to reproductive toxicity (see section 5.3).
Croatian: Istraživanja na životinjama nisu dostatna kada je riječ o reproduktivnoj toksičnosti (vidjeti dio 5.3).
English: A limited number of non-Caucasian, especially Black patients (2.6%) were included.
Croatian: U ispitivanje je bio uključen ograničen broj bolesnika koji nisu bili bijele rase, a osobito bolesnika crne rase (2,6%).
English: Pre-specified analyses for OS and PFS by stratification factors were performed.
Croatian: Provedene su unaprijed određene analize za OS i PFS prema stratifikacijskim faktorima.
English: To achieve the required infusion duration of approximately 60 minutes, the maximum infusion rate of 25 mg/minute should not be exceeded, instead the infusion duration should be increased.
Croatian: Da bi se postiglo potrebno trajanje infuzije od 60 minuta, ne smije se premašiti maksimalna brzina infuzije od 25 mg/min, nego umjesto toga treba produljiti trajanje infuzije.
English: Tell your doctor if you experience any of the following other side effects:
Croatian: Obavijestite svog liječnika ako primijetite bilo koju od sljedećih ostalih nuspojava:
English: Median OS in patients who did not experience neutropenia was 10.7 months in both arms.
Croatian: Medijan OS-a u bolesnika koji nisu imali neutropeniju iznosio je 10,7 mjeseci u obje skupine.
English: This is a specialised protein that can recognise and attach to another protein found on blood vessels called ‘VEGF receptor 2'.
Croatian: To je specijalizirani protein koji može prepoznati i pričvrstiti se za jedan drugi protein koji se nalazi na krvnim žilama, a zove se „VEGF receptor 2“.
English: Severe bleeding
Croatian: Teško krvarenje
English: In the pivotal studies there is limited evidence that patients 65 years of age or older are at increased risk of adverse events compared to patients younger than 65 years old.
Croatian: Postoje ograničeni dokazi iz pivotalnih ispitivanja da bolesnici u dobi od 65 ili više godina imaju veći rizik za razvoj nuspojava u usporedbi s bolesnicima mlađima od 65 godina.
English: h Includes cases of nephrotic syndrome.
Croatian: h Uključuje slučajeve nefrotskog sindroma.